Latest current assets for AGN.CN: $360K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Algernon Pharmaceuticals (AGN.CN) currently reports a current assets of $360K as of May 2026. That compares with $230K in the prior-year period — up 53.7% year over year. Use the charts on this page to explore Algernon Pharmaceuticals's current assets history and peer comparisons.
Algernon Pharmaceuticals's current assets increased from $230K to $360K — a 53.7% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Algernon Pharmaceuticals reported $360K in current assets as of May 2026. That compares with $230K in the prior-year period — up 53.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $360K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Algernon Pharmaceuticals, and consider following AGN.CN for alerts when major investors trade the stock.
Algernon Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $360K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGN.CN with unrelated industries.